Dr. John L. Meisenheimer Jr., MD

Dr. Meisenheimer practices at The Meisenheimer Clinic - Dermatology and Mohs Surgery in Orlando, Florida.

Dr. Meisenheimer's NPI, 1033101647, was assigned on August 19, 2005. Dr. Meisenheimer graduated from University Of Kentucky College Of Medicine in 1983. Dr. Meisenheimer holds Florida license ME49727.

Dr. Meisenheimer's primary practice is The Meisenheimer Clinic - Dermatology and Mohs Surgery, at 7300 Sandlake Commons Blvd, Orlando, FL 32819-8050. The practice phone is (407) 352-2444.

Dr. Meisenheimer's primary practice is The Meisenheimer Clinic - Dermatology and Mohs Surgery in Orlando, Florida.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meisenheimer practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Meisenheimer's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Meisenheimer is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Meisenheimer's licenses on file in 2 states: Florida and South Carolina.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes and scalp rash among the conditions Dr. Meisenheimer treats.

CMS data shows 7,855 Medicare services from Dr. Meisenheimer across 27 procedure codes in 2024, for 741 Medicare patients. Medicare paid $838,902 for them. Every service was in an office.

CMS counts 741 Medicare patients who saw Dr. Meisenheimer in 2024. The largest group is 75 to 84, with 330 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Meisenheimer's median patient age at 74, with 47% women.

In 2024, Dr. Meisenheimer wrote 225 Medicare Part D claims for 130 patients. 100% of them were for generic drugs. CMS names the drug for 168 of them, across 6 drugs with 11 or more claims each, at $4,848 in total drug cost. In 2023, CMS named 187 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Meisenheimer for performance year 2024, reported individually. Dr. Meisenheimer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,558 procedures of skin biopsy by Dr. Meisenheimer, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Meisenheimer.

CMS Open Payments shows 28 general payments to Dr. Meisenheimer from 17 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 90% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $89.

Dmand AI lists 2 awards for Dr. Meisenheimer.

Dr. Meisenheimer graduated from University Of Kentucky College Of Medicine in 1983. Dr. Meisenheimer is a member of AAD, AMA, ASDS, American Society of Contact Dermatitis, American Society of Mohs Surgery and American Swimming Coaches Association.

Dr. Meisenheimer is in network with 3 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.